RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Camptothecin compounds which are effective anti-tumor compounds
are disclosed. These conjugates inhibit the enzyme topoisomerase I
and enhance the stability of the topoisomerase I-DNA cleavable
complex.